Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FITCHBURG, Mass., March 22, 2017 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified...
-
FITCHBURG, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”) announced that effective on Friday, March 24, 2017 its corporate name will...
-
FITCHBURG, Mass., June 01, 2016 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified...
-
FITCHBURG, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified...
-
FITCHBURG, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified...
-
FITCHBURG, Mass., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), announced today the appointment of Mr. Bryan S. Ganz to its Board of...
-
FITCHBURG, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the "Company"), through its wholly-owned subsidiary, Micron Products, Inc., a diversified...
-
FITCHBURG, Mass., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has expanded...
-
FITCHBURG, Mass., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE:HRT), announced that it has entered into an...
-
Achieved second quarter net sales of $5.7 million and diluted earnings per share of $0.04 $370 thousand increase in net income from continuing operations compared with the trailing first...